The increasing trend of inhaling 5MeO copyright in Canada presents significant hazards and complex juridical problems. Currently, 5MeO dimethyltryptamine remains a Schedule Number One substance within this legislation, causing its possession and distribution prohibited. While inhalation delivers the chemical swiftly, it also presents new medical th